AngelaDeMicheleMDMSCE

PubMed

• 109 citations
  Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies.
  Denise M Wolf, Christina Yau, Julia Wulfkuhle, Lamorna Brown-Swigart, Rosa I Gallagher
  Cancer Cell. 2022-06-13
• 151 citations
  Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial
  Lajos Pusztai, Christina Yau, Denise M. Wolf, Hyo S. Han, Lili Du
  Cancer Cell. 2021-07-12
• 116 citations
  Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Can...
  Douglas Yee, Angela DeMichele, Christina Yau, Claudine Isaacs, W. Fraser Symmans
  JAMA Oncology. 2020-09-01

Journal Articles

• Distinct Microbial Signatures Associated with Different Breast Cancer Types  
  Angela M. DeMichele, Michael D. Feldman, Frontiers in Neurology
• Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer  
  Austin D Williams, Amy S Clark, Paul J Zhang, Julia Tchou, Bruce L Levine, Jennifer M Matro, Laurence J Cooper, Alycia So, Lynn M Schuchter, Carl H June, Angela M DeMi..., Clinical Cancer Research
• A randomized trial of electro-accupuncture for arthralgia related to aromatase inhibitor use  
  Mao JJ, Xie SX, Farrar JT, Stricker CT, Bowman MA, Bruner D, DeMichele A, European Journal of Cancer, 1/1/2014
• Validation of QuickDASH outcome measure in breast cancer survivors for upper extremity disability  
  LeBlanc M, Stineman M, DeMichele A, Stricker C, Mao JJ, Archives of Physical Medicine and Rehabilitation, 1/1/2014
• Pretreatment vitamin D level and response to neoadjuvant chemotherapy in women with breast cancer on the I-SPY Trial (CALGB 150007)  
  Clark AS, Chen J, Kapoor S, Friedman C, Mies C, Esserman L, DeMichele A, I-SPY1 Investigators, Cancer Medicine, 1/1/2014
• Expectancy in real and sham acupuncture: does believing make it so?  
  Bauml J, Xie S, Farrar J, Bruner D, Stricker C, Bowman M, DeMichele A, Mao J, Journal of Alternative and Complementary Medicine, 1/1/2014
• Metrics to evaluate treatment summaries and survivorship care plans: A scorecard  
  Palmer SC, Jacobs LA, DeMichele A, Risendal B, Jones AF, Stricker CT, Supportive Care in Cancer, 1/1/2014
• Physical Activity and Telomere length in early stage breast cancer Survivors  
  Garland SN, Johnson B, Palmer C, Speck RM, Donelson M, Xie SX, DeMichelle A, Breast Cancer, 1/1/2014
• Acclerated approval for pertuzumab in the neoadjvuant setting: Winds of change?  
  Esserman L, DeMichele A, Clinical Cancer Research, 1/1/2014
• Impact of chemotherapy-induced peripheral neuropathy on treatment delivery in non-metastatic breast cancer  
  Speck RM, Sammel MD, Farrar JT, Hennessy S, Mao JJ, Stineman MG, DeMichele A, Journal of Oncology Practice, 1/1/2013
• Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors  
  Chim K, Xie SX, Stricker CT, Li QS, Gross R, Farrar JT, DeMichele A, Mao JJ, BMC Cancer, 1/1/2013
• Association of progesterone receptor gene (PGR) variants and breast cancer risk in African American women  
  Gabriel CA, Mitra N, DeMichele A, Rebbeck T, Breast Cancer Research and Treatment, 1/1/2013
• Developing Safety Criteria for Introducing New Agents into Neoadjuvant Trials  
  Demichele A, Berry DA, Zujewski J, Hunsberger S, Rubinstein L, Tomaszewski JE, Kelloff G, Perlmutter J, Buxton M, Lyandres J, Albain KS, Benz C, Jo Chien A, Haluska P,..., Clinical Cancer Research, 1/1/2013
• mir-30d regulated multiple genes in the autophagy pathway and impairs autophagy process in human cancer  
  Yang X, Zhong X, Tanyi JL, Shen J, Xu C, Gao P, Zheng TM, DeMichele A, Zhang L, Biochem Biophys Res Commun, 1/1/2013
• Prevalence and risk factors for insomnia among breast cancer patients on aromatase inhibitors  
  Desai K, Mao JJ, Su I, DeMichele A, Li Q, Xie SX, Gehrman PR, Supportive Care in Cancer, 1/1/2013
• A genome-wide association study of breast cancer in women of African ancestry  
  Chen F, Chen GK, Stram DO, Millikan RC, Ambrosone CB, John EM, Bernstein L, Zheng W, Palmer JR, Hu JJ, Rebbeck TR, Ziegler RG, Nyante S, Bandera EV, Ingles SA, Press M..., Human Genetics, 1/1/2012
• CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients  
  Rech AJ, Mick R, Martin S, Recio A, Aqui NA, Powell DJ Jr, Colligon TA, Trosko JA, Leinback LI, Pletcher CH, Tweed CK, DeMichele A, Fox KR, Domchek SM, Riley JL, Vonde..., Science Translational Medicine, 1/1/2012
• Is screening effective in detecting untreated psychiatric disorders among newly diagnosed breast cancer patients?  
  Palmer SC, Taggi A, DeMichele A, Coyne JC, Cancer, 1/1/2012
• Vitamin D Deficiency in Post-menopausal Breast Cancer Survivors  
  Freidman C, DeMichele A, Su HI, Feng R, Kapoor S, Desai K, Mao JJ, Journal of Women's Health, 1/1/2012
• Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 15007/150012: ACRI...  
  Esserman LJ, Berry DA, Cheang MC, Yau C, Perou CM, Carey L, DeMichele A, Gray JW, Conway-Dorsey K, Lenburg ME, Buxton MB, Davis SE, Van't Veer LJ, Hudis C, Chin K, Wol..., Breast Cancer Research and Treatment, 1/1/2012
• Adaptive Trials in the Neoadjuvant Setting: A Model to Safely Tailor Care While Accelerating Drug Development  
  Yee D, Haddad T, Albain K, Barker A, Benz C, Boughey J, Buxton M, Jo Chien A, DeMichele A, Dilts D, Elias A, Haluska P, Hogarth M, Hu A, Hytlon N, Kaplan HG, Kelloff G..., Journal of Clinical Oncology, 1/1/2012
• Phase 1, Dose-escalation Trial of the Oral Cyclin-dependent Kinase 4/6 Inhibitor PD 0332991, Administered Using a 21-day Schedule in Patients with Advanced Cancer  
  Flaherty KT, Lorusso PM, Demichele A, Abramson VG, Courtney R, Randolph SS, Shaik MN, Wilner KD,O'Dwyer PJ, Schwartz GK, Clinical Cancer Research, 1/1/2012
• Scope of symptoms and self-management strategies for chemotherapy-induced peripheral neuropathy in breast cancer patients  
  Speck RM, DeMichele A, Farrar JA, Hennessy S, Mao JJ, Stineman MG and Barg FK, Supportive Care in Cancer, 1/1/2012
• The role of lapatinib in the preoperative therapy of breast cancer  
  Hirsh RL, DeMichele A, Curr Oncology Rep, 1/1/2012
• Taste alteration in breast cancer patients treated with taxane chemotherapy: experience, effect, and coping strategies  
  Speck RM, DeMichele A, Farrar JT, Hennessy S, Mao JJ, Stineman MG, Barg FK, Supportive Care in Cancer, 1/1/2012
• Join now to see all

Books/Book Chapters

• Am Soc Clin Oncol Educ Book 
  Chapter: Drug development: Neoadjuvant opportunities in breast cancer. 
  Page 73 - 79Rastogi P, Geyer CE, Mamounas EP, Demichele A2013
• American Society of Clinical Oncology Education Book 
  Chapter: Adherence to Oral Cancer Therapies: Challenges and Opportunities. 
  Partridge A, Kato P, DeMichele AAmerican Society of Clinical Oncology2010
• Textbook of Clinical Trials 
  Chapter: Systematic Review and Meta-Analysis. 
  Brunelli SM, DeMichele A, Guevara J, Berlin J2010
• Diseases of the Breast 
  Chapter: Loco-Regional Recurrence After Breast Conservation Therapy or Mastectomy. 
  Solin LJ, Harris E, Orel S, DeMichele A, Tchou JEditors: Lippman M, Morrow M, Osborne K.Lippincott Williams and Wilkens2009
• Handbook of Cancer Survivorship 
  Chapter: Comprehensive long term follow-up: cancer survivorship centers. 
  Jacobs LJ., Alavi J., DeMichele A., Palmer S., Stricker C., Vaughn D.2007
• Clinical Oncology 
  Chapter: Cancer-Related Emergencies. 
  DeMichele AM, Glick JHEditors: Hall, L.American Cancer Society2001
• Geriatric Secrets 
  Chapter: Care of the Elderly Cancer Patient. 
  DeMichele AM, Greenberg RH, Vaughn DJEditors: Forciea M, Schwab E, Lavizzo-Mourey R.Hanley and Belfus, Philadelphia, PAEdition 2nd,1999
• Geriatric Secrets 
  Chapter: Cancer Screening in the Elderly. 
  DeMichele AM, Greenberg RH, Vaughn DJEditors: Forciea M, Schwab E, Lavizzo-Mourey R.Hanley and Belfus, Philadelphia, PAEdition 2nd,1999
• Diseases of the Breast 
  Chapter: Inherited Genetic Factors. 
  DeMichele AM, Weber BLEditors: Harris J, Morrow M, Lippman S.Harris J, Morrow M, Lippman, Philadelphia, PAEdition 2nd,1999
• Join now to see all

Abstracts/Posters

• A Phase II Trial of the CDK 4/6 Inhibitor PD0332991 in Advanced Breast Cancer.
  DeMichele A, Clark A, Tan KS, Heitjan D, Randolph S, Christensen J, Gallagher M, Lal P, Feldman M, Zhang P, Domchek S, Gogineni K, Keefe S, Rosen M, Fox K, O'Dwyer P, American Society of Clinical Oncology, 1/1/2013

Lectures

• "Neoadjvuant Therapy as a Mechanism for Drug Approval" 
  San Francisco, CA - 1/1/2014
• "San Antonio Update 2013" 
  Morristown, NJ - 1/1/2014
• "Veliparib/carboplatin plus standard neoadjuvant therapy for high-risk breast cancer: First efficacy results from the I-SPY 2 TRIAL" 
  Philadelphia, PA - 1/1/2014
• "Palbociclib in Breast Cancer" 
  Washington, DC - 1/1/2014
• "The I-SPY2 Trial: A New Paradigm to Speed Drug Development and Approval" 
  Washington, DC - 1/1/2014
• "Drug Development in the Neoadjuvant Setting: Challenges and Opportunities" 
  Toronto, Canada - 1/1/2014
• "The I-SPY2 Trial: Using Biomarkers to Assess New Therapies in Early Breast Cancer" 
  Washington, DC - 1/1/2014
• "The I-SPY2 TRIAL: Early Results Evaluating New Agents for Breast Cancer" 
  Toronto, Canada - 1/1/2014
• "CDK 4/6 Inhibition in Breast Cancer" 
  Madrid, Spain - 1/1/2014
• "Design of the I-SPY2 Trial" 
  Brussels, Belgium - 1/1/2013
• Pushing the Limits of Upfront Care and Drug Development: Neoadjuvant Trial Opportunities in Breast Cancer. 
  Chicago, IL - 1/1/2013
• "Highlights of the San Antonio Breast Cancer Symposium: Targeted Therapy" 
  Fox Chase Cancer Center, Philadelphia, PA - 1/1/2013
• "SABCS 2012:Update on new targets, molecular tools and insights into triple negative disease" 
  Morristown, NJ - 1/1/2013
• "Challenges of Drug Development in the Neoadjuvant Setting" 
  Montreal - 1/1/2012
• "Clinical Trial Designs for New Therapies: What Agents Should Go into Trials?" 
  San Antonio, TX - 1/1/2012
• "Drug and Biomarker Development in Breast Cancer" 
  San Francisco, CA - 1/1/2012
• "Targeted therapy for advanced breast cancer: Past, present and the future" 
  Harrisburg, PA - 1/1/2012
• "Drug Development in the Neoadjuvant Setting: Lessons from the I-SPY2 Trial" 
  Hotel DelCoronado, CA - 1/1/2012
• "Neoadjuvant Clinical Trial Opportunities for ER+ Breast Cancer" 
  Bethesda, MD - 1/1/2012
• "I-SPY2: An adaptive trial of targeted therapy in the neoadjuvant treatment of breast cancer" 
  Bethesda, MD - 1/1/2012
• "Early-Stage Breast Cancer: Treatment and Living Well Beyond" 
  Philadelphia, PA - 1/1/2011
• "Cyclin Dependent Kinases as a Target for Breast Cancer Therapy." 
  Sun Valley, ID - 1/1/2011
• "Neoadjuvant Therapeutic and Biomarker Development: The ISPY Research Program" 
  Washington, DC - 1/1/2011
• Grand Rounds: "Triple Negative Breast Cancer: Implications for Southern Africa" 
  University of Botwana School of Medicine, Gabarone, Botswana - 1/1/2010
• "Breast Cancer Update: Abstracts from the 2010 ASCO National Meeting" 
  Carol G. Simon Cancer Center, Morristown Memorial Hospital, Morristown, NJ - 1/1/2010
• Join now to see all